UN backed group sub-licence drug
Pfizer has agreed to allow companies to make a generic version of its Covid treatment pill.
Data from the company says it reduces the risk of hospitalisation by 89 per cent.
The licensing agreement with the Medicines Patent Pool was announced today, and allows the UN backed group to issue sub-licences.
The drug will be administered alongside Ritanovir, which is widely used to treat HIV.

Social Media Could Change Forever If Meta Loses US Legal Battle, Says Experts
Efforts To Achieve Peace Plan For Gaza Continue As US Meet Middle East Mediators
US Military Fire On Ship In Gulf Of Oman
Over 250 People Now Confirmed Dead Following Devastating Earthquake In Colombia
Rescue Operation Continues After 160 Dead In Colombian Earthquake
Six Killed In School Shooting Near Bangkok In Thailand
Reports Of Iran And Oman Working Towards Deal To Reopen Strait Of Hormuz
EU Home Affairs Ministers Meet To Discuss Protection Of Borders From Illegal Migration